Release Date: 18/07/19 13:27 Summary: UPDATE ON SHARE BUYBACK ANNOUNCED DECEMBER 2018 Price Sensitive: Yes Download Document 217.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%